Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Multiple Myeloma 3Neoplasms 1Neoplasm Metastasis 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Immunoblastic Lymphadenopathy 1Enteropathy-Associated T-Cell Lymphoma 1

Interventions

Cyclophosphamide 7fludarabine phosphate 5tanespimycin 4Cyclosporine 4Vincristine 3Peripheral Blood Stem Cell Transplantation 3Irinotecan 3Doxorubicin 3Bortezomib 3Antilymphocyte Serum 3nelarabine 2laromustine 2fludarabine 2entinostat 2belinostat 2alvocidib 2Vorinostat 2Psychiatric Rehabilitation 2Prednisone 2Pharmacogenomic Testing 2Oxaliplatin 2Mycophenolic Acid 2Methylprednisolone 2Magnetic Resonance Spectroscopy 2MLN 8237 2Levofloxacin 2Lenalidomide 2Gemcitabine 2Flow Cytometry 2Carboplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Immunoblastic Lymphadenopathy × Receptors, Chimeric Antigen × Clear all
NCT03049449 2023-01-18

T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
26 enrolled 19 charts
Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Extranodal NK-T-Cell, Enteropathy-Associated T-Cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡